相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz et al.
BONE MARROW TRANSPLANTATION (2021)
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia
Cosimo Cumbo et al.
LEUKEMIA & LYMPHOMA (2021)
Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia
Eman O. Rasekh et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
Stephen S. Y. Lam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study
Sabine Kayser et al.
LEUKEMIA (2020)
The prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia
Lu Nie et al.
LEUKEMIA & LYMPHOMA (2020)
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias
Cecile Esnault et al.
BLOOD (2019)
Influence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide
Shahid M. Baba et al.
CANCER GENETICS (2019)
The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
Gledson L. Picharski et al.
CANCERS (2019)
The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia
Yingchao Fan et al.
HEMATOLOGY (2018)
Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA
Ardeshir Ghavamzadeh et al.
LEUKEMIA RESEARCH (2018)
Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways
Li-Na Wang et al.
LEUKEMIA & LYMPHOMA (2017)
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
L. Cicconi et al.
LEUKEMIA (2016)
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study
Antonio R. Lucena-Araujo et al.
ANNALS OF HEMATOLOGY (2014)
Acute promyelocytic leukemia: What is the new standard of care?
Justin M. Watts et al.
BLOOD REVIEWS (2014)
ATRA plus ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia?
Massimo Breccia et al.
CURRENT OPINION IN HEMATOLOGY (2014)
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype
Xavier Poire et al.
LEUKEMIA & LYMPHOMA (2014)
FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis
Massimo Breccia et al.
HAEMATOLOGICA (2013)
Bleeding and thrombosis in acute promyelocytic leukemia
Aditi Choudhry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Harry Iland et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Miguel A. Sanz et al.
BLOOD (2010)
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Javier de la Serna et al.
BLOOD (2008)
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia
RE Gale et al.
BLOOD (2005)
Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia
F Kuchenbauer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia -: Correlation with molecular subtypes of PML/RARα and clinical features
LY Shih et al.
CANCER (2003)
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
N Noguera et al.
LEUKEMIA (2002)
分享论文
